Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - NetLoans - NetMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Short term Debt (2016 - 2023)

Creative Medical Technology Holdings has reported Short term Debt over the past 14 years, most recently at $14194.0 for Q1 2023.

  • Quarterly Short term Debt changed 0.0% to $14194.0 in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $14194.0 through Mar 2023, changed 0.0% year-over-year, with the annual reading at $14194.0 for FY2022, 0.0% changed from the prior year.
  • Short term Debt was $14194.0 for Q1 2023 at Creative Medical Technology Holdings, roughly flat from $14194.0 in the prior quarter.
  • Over five years, Short term Debt peaked at $38.7 million in Q4 2020 and troughed at $10800.0 in Q1 2020.
  • The 5-year median for Short term Debt is $23497.0 (2021), against an average of $3.4 million.
  • Biggest five-year swings in Short term Debt: surged 63306.27% in 2019 and later tumbled 99.96% in 2021.
  • Tracing CELZ's Short term Debt over 5 years: stood at $6.8 million in 2019, then surged by 465.75% to $38.7 million in 2020, then tumbled by 99.96% to $14194.0 in 2021, then changed by 0.0% to $14194.0 in 2022, then changed by 0.0% to $14194.0 in 2023.
  • According to Business Quant data, Short term Debt over the past three periods came in at $14194.0, $14194.0, and $14194.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.